"The Washington Health Institute (WHI) was founded with the mission to improve the health of our community by providing exceptional Primary Care, Sexual Health and Infectious Diseases Specialty care services. We approach the unique needs of each patient by providing holistic care support and patient education, while participating in innovative research that advances the quality of life for our patients. Call or email us today to get connected to high-quality, patient-centered care!"

During the past decade, Washington Health Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington Health Institute" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials, followed by "Gilead Sciences" with 5 trials sponsored, "American Gene Technologies International Inc." with 3 trials sponsored, "George Washington University" with 2 trials sponsored and "ModernaTX, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Health Institute" #1 collaborator was "Chiron Corporation" with 2 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 2 trials as a collaborator, "Excelsus Statistics Inc." with 1 trials as a collaborator, "Health Psychology Research Group (HPR)" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Washington Health Institute" are "HIV Infections" (9 trials), "HIV" (4 trials), "HIV-1 Infection" (2 trials), "HIV-1-infection" (2 trials) and "AIDS" (1 trials). Many other conditions were trialed in "Washington Health Institute" in a lesser frequency.

Most popular intervention types in "Washington Health Institute" are "Drug" (9 trials), "Biological" (5 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "B/F/TAF" (3 trials), "Oral Lenacapavir" (2 trials), "Subcutaneous Lenacapavir" (2 trials), "AGT103-T" (1 trials) and "Antiretroviral Regimens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington Health Institute" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Washington Health Institute". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 10 completed trials in Washington Health Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Washington Health Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".